Revvity, Inc.
RVTY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 4 days ago • RVTY
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Zacks Investment Research • 10 days ago • RVTY
Revvity (RVTY) Up 9.5% Since Last Earnings Report: Can It Continue?
Seeking Alpha • 19 days ago • RVTY
Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript
Seeking Alpha • 27 days ago • RVTY
Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript
Business Wire • 27 days ago • RVTY
Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.